The Role of Tetraspanin CD37 in B-Cell Malignancy

被引：0
|
作者：
Beckwith, Kyle A. [1 ]
Williams, Erich I. [2 ]
Wright, Mark D. [3 ]
van Spriel, Annemiek B. [4 ]
Byrd, John C. [2 ,5 ]
Muthusamy, Natarajan [2 ,6 ]
机构：
[1] Ohio State Univ, Dept Med, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
[3] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia
[4] Radboud Univ Nijmegen, Med Ctr, Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands
[5] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA
[6] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The role of the tetraspanin CD37 in T and B cell responses
    Wright, M
    Van Spriel, AB
    Gartlan, K
    Nastovska, R
    Sofi, M
    Daunt, C
    Sheng, KC
    Apostolopoulos, V
    Pietersz, G
    Light, A
    Tarlinton, D
    TISSUE ANTIGENS, 2005, 66 (05): : 593 - 593
  • [2] Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
    Rens Peeters
    Jorge Cuenca-Escalona
    Esther A. Zaal
    Anna T. Hoekstra
    Anouk C. G. Balvert
    Marcos Vidal-Manrique
    Niek Blomberg
    Sjoerd J. van Deventer
    Rinke Stienstra
    Julia Jellusova
    Martin Giera
    Luciana Hannibal
    Ute Spiekerkoetter
    Martin ter Beest
    Celia R. Berkers
    Annemiek B. van Spriel
    Nature Communications, 13
  • [3] Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
    Peeters, Rens
    Cuenca-Escalona, Jorge
    Zaal, Esther A.
    Hoekstra, Anna T.
    Balvert, Anouk C. G.
    Vidal-Manrique, Marcos
    Blomberg, Niek
    van Deventer, Sjoerd J.
    Stienstra, Rinke
    Jellusova, Julia
    Giera, Martin
    Hannibal, Luciana
    Spiekerkoetter, Ute
    Ter Beest, Martin
    Berkers, Celia R.
    van Spriel, Annemiek B.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Tetraspanin CD37 protects against the development of B cell lymphoma
    de Winde, Charlotte M.
    Veenbergen, Sharon
    Young, Ken H.
    Xu-Monette, Zijun Y.
    Wang, Xiao-xiao
    Xia, Yi
    Jabbar, Kausat J.
    van den Brand, Michiel
    van der Schaaf, Alie
    Elfrink, Suraya
    van Houdt, Inge S.
    Gijbels, Marion J.
    van de Loo, Fons A. J.
    Bennink, Miranda B.
    Hebeda, Konnie M.
    Groenen, Patricia J. T. A.
    van Krieken, J. Han
    Figdor, Carl G.
    van Spriel, Annemiek B.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 653 - 666
  • [5] PROTECTION AGAINST DEVELOPMENT OF B CELL LYMPHOMA BY TETRASPANIN CD37
    de Winde, C.
    Veenbergen, S.
    Young, K.
    van den Brand, M.
    van der Schaaf, A.
    Elfrink, S.
    van Krieken, H.
    Figdor, C.
    van Deventer, S.
    Scheijen, B.
    Van Spriel, A.
    HAEMATOLOGICA, 2017, 102 : 557 - 557
  • [6] Tetraspanin CD37 as regulator of mast cell responses
    Orinska, Z.
    Bulfone-Paus, S.
    IMMUNOLOGY, 2013, 140 : 38 - 38
  • [7] The tetraspanin CD37 promotes dendritic cell migration
    Demaria, M. C.
    Gartlan, K. H.
    Wee, J.
    Hickey, M. J.
    Wright, M. D.
    IMMUNOLOGY, 2012, 137 : 285 - 286
  • [8] CD37 tetraspanin as a novel biomarker for PD-1 blockade in diffuse large B-cell lymphoma
    Xu-Monette, Zijun Y.
    Young, Ken H.
    CANCER RESEARCH, 2017, 77
  • [9] Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions
    Knobeloch, KP
    Wright, MD
    Ochsenbein, AF
    Liesenfeld, O
    Löhler, J
    Zinkernagel, RM
    Horak, I
    Orinska, Z
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) : 5363 - 5369
  • [10] A Transgenic Mouse Model of Aggressive B-Cell Malignancy for Evaluating Anti-Human CD37 Therapeutics
    Beckwith, Kyle A.
    Frissora, Frank W.
    Stefanovski, Matthew R.
    Deckert, Jutta
    Croce, Carlo M.
    Mo, Xiaokui
    Jarjoura, David
    Byrd, John C.
    Muthusamy, Natarajan
    BLOOD, 2012, 120 (21)
12345